The present study aimed to investigate the potential impact of KRT7 mRNA expression on the treatment response and prognosis of patients with advanced lung adenocarcinoma who underwent first-line platinum-based chemotherapy. The gene discussed is KRT7; the disease is lung adenocarcinoma.